US Stock MarketDetailed Quotes

INTS Intensity Therapeutics

Watchlist

1.860
+0.110+6.29%

Close Jan 3 16:00 ET

28.09MMarket Cap-1.59P/E (TTM)

Intensity Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Intensity Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Intensity Therapeutics Earnings Reports

Intensity Therapeutics | 8-K: Intensity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 13, 2024 16:16 ET

Intensity Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13, 2024 16:03 ET

Intensity Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8, 2024 16:43 ET

Intensity Therapeutics | 8-K: Intensity Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 8, 2024 16:39 ET

Analyst Rating

Updated: Dec 31, 2024

Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall